Invention Grant
US08828929B2 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof
有权
用于SARS冠状病毒的细胞毒性T细胞表位肽及其用途
- Patent Title: Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof
- Patent Title (中): 用于SARS冠状病毒的细胞毒性T细胞表位肽及其用途
-
Application No.: US13131560Application Date: 2009-11-27
-
Publication No.: US08828929B2Publication Date: 2014-09-09
- Inventor: Masanori Matsui , Tetsuya Uchida , Hiroshi Oda
- Applicant: Masanori Matsui , Tetsuya Uchida , Hiroshi Oda
- Applicant Address: JP Tokyo JP Saitama JP Tokyo
- Assignee: Nof Corporation,Saitama Medical University,Japan as Represented by Director-General of National Institute of Infectious Diseases
- Current Assignee: Nof Corporation,Saitama Medical University,Japan as Represented by Director-General of National Institute of Infectious Diseases
- Current Assignee Address: JP Tokyo JP Saitama JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JPP2008-304965 20081128
- International Application: PCT/JP2009/070043 WO 20091127
- International Announcement: WO2010/061919 WO 20100603
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K38/08 ; A61K9/127 ; C07K7/06 ; A61P31/12 ; A61K39/215 ; C07K14/005 ; A61K39/00
Abstract:
The present invention aims to provide a novel CTL epitope peptide of the SARS coronavirus. The present invention provides a peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs: 10, 11, 12, 13, 15, 17, 18, 23 and 24.
Public/Granted literature
- US20110262529A1 CYTOTOXIC T CELL EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND USE THEREOF Public/Granted day:2011-10-27
Information query
